Sunrise Group secures FDA clearance for home sleep test

Sunrise Group has secured the US Food and Drug Administration (FDA) clearance for its latest rechargeable at-home sleep test, Sunrise Air. The lightweight, at-home sensor records MJM, a validated biosignal for sleep evaluation. Sunrise Air aims to deliver laboratory-level data accessibly, removing many limitations present in traditional sleep laboratories. Credit: PeopleImages / Shutterstock.com. Sunrise Group has secured the US Food and Drug Administration (FDA) clearance for Sunrise Air, its latest rechargeable at-home sleep test. This development advances Sunrise’s efforts to broaden access to sleep diagnostics through clinically robust, at-home solutions for sleep apnoea assessment. Cloud in Healthcare: Sleep Monitoring Devices…

Source: Medical Device Network